# Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension

> **NCT00332072** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 541 (actual)

## Conditions studied

- Ocular Hypertension

## Interventions

- **DRUG:** bimatoprost/timolol fixed combination

## Key facts

- **NCT ID:** NCT00332072
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 541 (ACTUAL)
- **Last updated:** 2011-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00332072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00332072, "Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00332072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*